Ms Lorana Ard, MS, CCC-SLP is a
Speech-language Pathologist based in Sunnyside, Washington. Ms Lorana Ard is licensed to practice in Washington (license number LL60628814) and her current practice location is
721 Otis Ave, Sunnyside, Washington. She can be reached at her office (for appointments etc.) via phone at
(509) 837-2122.
NPI number for Ms Lorana Ard is 1487034377 and her current mailing address is 721 Otis Ave, Sunnyside, Washington. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1487034377.
Healthcare Provider's Profile
Full Name | Ms Lorana Ard |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 721 Otis Ave, Sunnyside, Washington |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1487034377
- Provider Enumeration Date: 06/04/2015
- Last Update Date: 03/26/2021
Medical Identifiers
Medical identifiers for Ms Lorana Ard such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1487034377 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | SLP8371 (Arizona) | Secondary |
235Z00000X | Speech-language Pathologist | LL60628814 (Washington) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Lorana Ard is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Ms Lorana Ard, MS, CCC-SLP 721 Otis Ave, Sunnyside, WA 98944-2328 Ph: (509) 837-2122 | Ms Lorana Ard, MS, CCC-SLP 721 Otis Ave, Sunnyside, WA 98944-2328 Ph: (509) 837-2122 |
Reviews and Comments